Based on our recent findings, in this study we aimed to verify whether methylation of SERPINA1 gene promoter may differ between ACS patients with COPD (COPD+) and without COPD (COPD−). This evidence concerns the gene SERPINA1 and chronic obstructive pulmonary disease.